Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Cooper

Showing results (151-160 of 245) with videos related to

Pageof 25
Sort By:
Cancer|August 15, 1982
Nonseminomatous germ-cell cancer of the testisB R Paschal, H B Muss, F Richards, et al.
Cancer Research|September 1, 1981
Pharmacokinetics of vincristine sulfate in adult cancer patientsV S Sethi, D V Jackson, D R White, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985
Phase II study of recombinant alpha-2 interferon in resistant multiple myelomaJ J Costanzi, M R Cooper, J H Scarffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suraminR J Bitton, W D Figg, D J Venzon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B studyB A Parker, M Santarelli, M R Green, et al.
Surgery|July 1, 1994
Postoperative complications in patients receiving suramin therapyD J Cole, S E Ettinghausen, H I Pass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Cancer Treatment Reports|April 1, 1982
Effect of age on therapeutic response and survival in advanced Hodgkin's diseaseB A Peterson, T F Pajak, M R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Pageof 25

Showing results (151-160 of 245) with videos related to

Sort By:
Pageof 25
Cancer|August 15, 1982
Nonseminomatous germ-cell cancer of the testisB R Paschal, H B Muss, F Richards, et al.
Cancer Research|September 1, 1981
Pharmacokinetics of vincristine sulfate in adult cancer patientsV S Sethi, D V Jackson, D R White, et al.
Cancer Treatment Reports|April 1, 1986
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trialM R Cooper, A Fefer, J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1985
Phase II study of recombinant alpha-2 interferon in resistant multiple myelomaJ J Costanzi, M R Cooper, J H Scarffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suraminR J Bitton, W D Figg, D J Venzon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: a Cancer and Leukemia Group B studyB A Parker, M Santarelli, M R Green, et al.
Surgery|July 1, 1994
Postoperative complications in patients receiving suramin therapyD J Cole, S E Ettinghausen, H I Pass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabineK R Rai, C E Freter, R J Mercier, et al.
Cancer Treatment Reports|April 1, 1982
Effect of age on therapeutic response and survival in advanced Hodgkin's diseaseB A Peterson, T F Pajak, M R Cooper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB StudyM R Cooper, O R McIntyre, K J Propert, et al.
Pageof 25